Trial Profile

A phase II/III trial of Cannabidiol/tetrahydrocannabinol chewing gum (MedChew RX) for the treatment of pain and spasticity in patients with multiple sclerosis

Status: Planning

Phase of Trial: Phase II/III

Latest Information Update: 22 Oct 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

16 Oct 2018 According to an Axim Biotech media release, the company has received a manufacturing license from the Dutch Ministry of Health, Welfare and Sports for the production, according to Good Manufacturing Practices of the companys pharmaceutical products to be used in clinical trials.Under the new GMP license, AXIM will begin production of its flagship pharmaceutical product MedChew Rx, which will undergo this clinical trial.
08 Feb 2016 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com